Namenda | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Namenda
HEALTH CANADA PATENTS

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Namenda

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

65 API Suppliers, 34 USDMF, 11 JDMF, 15 EU WC, 26 KDMF, 30 NDC API, 36 Listed Suppliers, $ API Reference Price

65 API Suppliers
34 USDMF
11 JDMF
15 EU WC
26 KDMF
30 NDC API
36 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

14 API Suppliers

14 API Suppliers

FINISHED DOSAGE FORMULATIONS

479 FDF Dossiers, 125 FDA Orange Book, 244 Europe, 11 Canada, 14 Australia, 9 South Africa, 76 Listed Dossiers

479 FDF Dossiers
125 FDA Orange Book
244 Europe
11 Canada
14 Australia
9 South Africa
76 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 5MG, CAPSULE, EXTENDED RELEASE;ORAL - 14MG, CAPSULE, EXTENDED RELEASE;ORAL - 21MG, CAPSULE, EXTENDED RELEASE;ORAL - 28MG, CAPSULE, EXTENDED RELEASE;ORAL - 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG
TABLET;ORAL - 5MG
CAPSULE, EXTENDED RELEASE;ORAL - 14MG
CAPSULE, EXTENDED RELEASE;ORAL - 21MG
CAPSULE, EXTENDED RELEASE;ORAL - 28MG
CAPSULE, EXTENDED RELEASE;ORAL - 7MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 8 SPI Pharma, 2 Seqens, 8 DKSH, 2 Jai Radhe Sales, 1 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 16 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 11 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 26 BASF, 1 Bioplus Life Sciences, 2 Clariant, 11 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 8 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

89 Fillers, Diluents & Binders, 60 Coating Systems & Additives, 38 Direct Compression, 37 Controlled & Modified Release, 35 Disintegrants & Superdisintegrants, 29 Thickeners and Stabilizers, 26 Film Formers & Plasticizers, 26 Granulation, 25 Lubricants & Glidants, 20 Solubilizers, 19 Topical, 19 Taste Masking, 18 Co-Processed Excipients, 17 Parenteral, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 7 Emulsifying Agents, 6 API Stability Enhancers, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

89 Fillers, Diluents & Binders
60 Coating Systems & Additives
38 Direct Compression
37 Controlled & Modified Release
35 Disintegrants & Superdisintegrants
29 Thickeners and Stabilizers
26 Film Formers & Plasticizers
26 Granulation
25 Lubricants & Glidants
20 Solubilizers
19 Topical
19 Taste Masking
18 Co-Processed Excipients
17 Parenteral
10 Chewable & Orodispersible Aids
9 Empty Capsules
7 Emulsifying Agents
6 API Stability Enhancers
5 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 85 NEWS #PharmaBuzz

4 DATA COMPILATION #PharmaFlow
85 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 174 Finished Drug Prices, 13 Annual Reports

3 US Medicaid Prescriptions
174 Finished Drug Prices
13 Annual Reports

MARKET PLACE

14 APIs, 5 FDF Dossiers

14 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

66 US Patents, 2 Health Canada Patents

66 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 USP, 15 Others

6 USP
15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 548 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Lundbeck Canada Inc.

02 1Blank

filter Patent Reset all filters

2 All

01 12014453

02 12426492

filter Product Reset all filters

2 All

01 1Memantine Hydrochloride

02 1Blank

filter Dosage Reset all filters

2 All

01 1Tablet

02 1Blank

filter Exp Date Reset all filters

2 All

01 12010-04-11

02 12023-05-08

Product Main Page

01

Lundbeck Canada Inc.

Memantine Hydrochloride

2024 ACI Convention

Not Confirmed

Lundbeck Canada Inc.

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-05-08

Date Granted : 2006-10-03

Memantine Hydrochloride

Brand Name : EBIXA

Patent Number : 2426492

Filing Date : 2003-05-08

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2023-05-08

Date Granted : 2006-10-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Memantine Hydrochloride

2024 ACI Convention

Not Confirmed

Country

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2010-04-11

Date Granted :

Memantine Hydrochloride

Brand Name :

Patent Number : 2014453

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2010-04-11

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?